ERBB2 and breast carcinoma: Future studies focusing on the effects of AZD4547 on tumor latency in MMTV-ErbB2 mice and other breast cancer models, and relative cellular toxicity in normal mice will be performed to further establish FGFR inhibitors for mammary tumor prevention.